MedPath
NMPA Approval

Parecoxib Sodium for Injection

国药准字H20193249

August 29, 2019

Drug Information

注射用帕瑞昔布钠

注射剂

40mg(按C19H18N2O4S计)

化学药品

August 29, 2019

Company Information

Applicant Company

广州高新技术产业开发区广州科学城香山路31号

Manufacturing Company

广州高新技术产业开发区广州科学城香山路31号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用帕瑞昔布钠 - NMPA 批准文号 | MedPath